Want to see AU:EIQ full AI Analyst Report?
EIQ Stock Chart & Stats
AU$1.40
AU$0.02(1.52%)
At close: 4:00 PM EDT
AU$1.40
AU$0.02(1.52%)
Day’s Range― - ―
52-Week RangeAU$0.17 - AU$1.88
Previous CloseN/A
Volume1.85M
Average Volume (3M)7.96M
Market Cap
AU$574.18M
Enterprise ValueAU$1.04K
Total Cash (Recent Filing)AU$8.71M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta1.65
Next Earnings
Mar 04, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding740,874,760
10 Day Avg. Volume17,582,948
30 Day Avg. Volume7,960,165
Financial Highlights & Ratios
PEG Ratio-2.18
Price to Book (P/B)89.24
Price to Sales (P/S)11280.71
P/FCF Ratio-97.75
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.91Price Target Upside-34.82% Downside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)-0.02
Revenue Forecast (FY)AU$1.76M
Bulls Say, Bears Say
Bulls Say
Minimal Financial LeverageMinimal borrowing reduces exposure to interest costs, refinancing pressure, and lender constraints. This gives EchoIQ a cleaner balance-sheet starting point and preserves more flexibility to allocate available resources toward product development and operations.
Focused Cardiovascular TechnologyA defined focus on cardiovascular health gives EchoIQ a clear domain for product development and commercialization. Concentrating technology around heart-health assessment may help align expertise, partnerships, and future offerings around a substantial healthcare need.
Revenue Improved In 2026The year-over-year revenue improvement indicates that the company has generated some progress in sales despite its small base. If this improvement can be sustained, it would provide a foundation for better operating leverage and broader commercial adoption.
Bears Say
Persistent Cash BurnContinued negative operating and free cash flow means the business is not yet self-funding its operations. Persistent cash consumption can increase reliance on existing reserves or external financing and may constrain investment in longer-term product development.
Deepening Losses And Weak MarginsWidening losses and heavily negative margins show that current revenue is insufficient to cover the company’s cost structure. Without meaningful improvement in profitability, growth may require additional funding and may not translate into durable shareholder value.
Eroding Equity BaseA declining equity base reflects the cumulative effect of ongoing losses and reduces the capital cushion available to support operations. Continued erosion could increase financing pressure and limit the company’s ability to pursue its technology strategy independently.
EchoIQ Limited News
EIQ FAQ
What was EchoIQ Limited’s price range in the past 12 months?
EchoIQ Limited lowest share price was AU$0.17 and its highest was AU$1.88 in the past 12 months.
What is EchoIQ Limited’s market cap?
EchoIQ Limited’s market cap is AU$574.18M.
When is EchoIQ Limited’s upcoming earnings report date?
EchoIQ Limited’s upcoming earnings report date is Mar 04, 2027 which is in 163 days.
How were EchoIQ Limited’s earnings last quarter?
EchoIQ Limited released its earnings results on Aug 28, 2026. The company reported -AU$0.015 earnings per share for the quarter.
Is EchoIQ Limited overvalued?
According to Wall Street analysts EchoIQ Limited’s price is currently Overvalued.
Does EchoIQ Limited pay dividends?
EchoIQ Limited does not currently pay dividends.
What is EchoIQ Limited’s EPS estimate?
EchoIQ Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EchoIQ Limited have?
EchoIQ Limited has 740,874,760 shares outstanding.
What happened to EchoIQ Limited’s price movement after its last earnings report?
EchoIQ Limited reported an EPS of -AU$0.015 in its last earnings report. Following the earnings report the stock price went down -7.616%.
Which hedge fund is a major shareholder of EchoIQ Limited?
Currently, no hedge funds are holding shares in AU:EIQ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
EchoIQ Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$0.91 (-34.82% Downside)
AU$0.91 (-34.82% Downside)
Blogger Sentiment
Bullish
AU:EIQ Sentiment 88%
Sector Average 63%
Sector Average 63%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
255.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-40.63%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
EchoIQ Limited
Echo IQ Limited engages in the provision of artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia. It offers EchoSolv, provides an AI-powered risk assessment of structural heart disease, including aortic stenosis, diastolic dysfunction, and heart failure. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. Echo IQ Limited is based in Claremont, Australia.
EIQ Stock 12 Month Forecast
Average Price Target
AU$0.91
▼(-34.82% Downside)
Technical Analysis
EQ Resources Limited
―
Minerals 260 Limited
―
Iperionx Limited
―
Vulcan Energy Resources Ltd.
―
Brazilian Rare Earths Ltd.
―









